Thursday, November 18, 2021 10:45:52 AM
Attached is a reminder of the bio of their most recent advisor addition, Dr. Catherine Sohn.
https://www.globenewswire.com/news-release/2021/10/12/2312778/0/en/CURATIVE-BIOTECHNOLOGY-ANNOUNCES-DR-CATHERINE-SOHN-AS-SPECIAL-ADVISOR-TO-BOARD-AND-CEO.html
Key quote from bio:
“Dr. Sohn started the U.S. Vaccine Business for SmithKline Beecham and led the launch of its first vaccine in the U.S. and helped shape their global vaccine portfolio pipeline as a member of the International Vaccine Steering Committee.”
Interesting timing of the company’s announcement of developing a novel Covid-19 vaccine for kidney failure patients (in line with their rare disease strategy) with her joining as an advisor. She started SmithKline Beecham’s vaccine business. Gotta believe she can open some doors and knows the process of developing products.
Recent CUBT News
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 05/06/2024 09:31:41 PM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM